Table of Contents Table of Contents
Previous Page  12 / 14 Next Page
Information
Show Menu
Previous Page 12 / 14 Next Page
Page Background

Page 33

April 15-16, 2019 | Milan, Italy

&

PUBLIC HEALTH,

EPIDEMIOLOGY AND NUTRITION

2

nd

World Congress on

CELL AND GENE THERAPY

2

nd

International Conference on

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

alliedacademies.com

YEARS

Joint Event on

Cell and Gene Therapy 2019 & Public Health Congress 2019

Archives of General Internal Medicine | ISSN: 2591-7951 | Volume 3

FROM PUBLIC HEALTH POINT

OF VIEW TO INVESTIGATE THE

CONTROL OF OBESITY, DIABETES,

AND CARDIOVASCULAR RISK VIA

NUTRITION AND EXERCISE

Introduction:

Public health data shows that, in 2017, USA had two mil-

lion deaths which diabetes, heart diseases, stroke and nephrosis occu-

pied 45% (~907,000). Furthermore, >85% of T2D patients are overweight

and >50% are obese.

Methods:

The author spent 20,000 hours during the past 8.5 years, us-

ing math-physical medicine to conduct his research. He has collected

and processed ~1.5 million data, including 300,000 medical conditions

and 1.2 million lifestyle details. He then utilized advanced mathematics,

optical physics, signal processing, energy and wave theories, statistics,

big data analytics, machine learning and artificial intelligence to develop

five predictionmodels, including weight, FPG, PPG, adjusted glucose and

HbA1C.

Results:

His clinical case studies have offered the following results: BMI

reduction from 32 (obese), to 24.7 (normal); FPG reduction from ~200

mg/dL to~105mg/dL; PPG from279mg/dL to 119mg/dL; Daily averaged

glucose from >250 mg/dL to ~116 mg/dL; HbA1C from 10% to <6.5%;

Risk reduction of having cardiovascular diseases and stroke from 70-90%

prior to 2010 (suffered 5 heart attacks) to 26.4% in 2017; Averaged carbs/

sugar intake amounts (38% contribution on PPG) are 14.5 gram/meal and

Gerald C Hsu, Arch Gen Intern Med 2019, Volume 3

DOI: 10.4066/2591-7951-C2-025

Gerald C Hsu received an honorable PhD in Math-

ematics and majored in Engineering at MIT. He

attended different universities over 17 years and

studied seven academic disciplines. He has spent

20,000 hours in T2D research. First, he studied

six metabolic diseases and food nutrition during

2010-2013, then conducted research during

2014-2018. His approach is “math-physics and

quantitative medicine” based on mathematics,

physics, engineering modelling, signal process-

ing, computer science, big data analytics, statis-

tics, machine learning and AI. His main focus is

on preventive medicine using prediction tools.

He believes that the better the prediction, the

more control you have.

g.hsu@eclairemd.com

Gerald C Hsu

EclaireMD Foundation, USA

BIOGRAPHY